November 6, 2024
Bethesda’s Vitrian Closes on $50M Initial Investment into Biomanufacturing Capacity & Launches Partnership with AmplifyBio
BETHESDA, Md. & WEST JEFFERSON, Ohio--(BUSINESS WIRE)--Vitrian, the leading end-to-end provider of investment capital and capacity building services for biomanufacturing,…
November 5, 2024
Catalyzing Crucial Cross-Border Collaborations and Innovation to Address Unmet Needs in Rare Diseases
The Indo US Bridging RARE Summit 2024 will spotlight the urgent need for cross-border collaborations to address disparities in rare…
November 4, 2024
Activation Capital Announces Frontier BioHealth Showcase Event
10 groundbreaking startups to pitch at Richmond's Main Street Station on November 20, 2024 RICHMOND, Va., Nov. 4, 2024 /PRNewswire/ -- Activation Capital, an innovation ecosystem…
November 4, 2024
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Germantown, Maryland, and Venlo, the Netherlands, Nov. 04, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today…
November 4, 2024
Baltimore’s LaunchPort Welcomes Previous Crab Trap Winner, Nanochon, from JLABS as New Resident
Nov 3, 2024 LaunchPort is pleased to announce that Nanochon (https://www.nanochon.com/) has joined their City Garage/Baltimore Peninsula location as a LaunchPort…
November 4, 2024
BioTalk Podcast – Connecting Innovation to Opportunity: A Conversation with Rachel Rath, Head of JLABS @ Washington, DC
In this episode of BioTalk, Rich Bendis sits down with Rachel Rath, the Head of JLABS @ Washington, DC, to…
November 4, 2024
BioTalk Podcast – Connecting Innovation to Opportunity: A Conversation with Rachel Rath, Head of JLABS @ Washington, DC
In this episode of BioTalk, Rich Bendis sits down with Rachel Rath, the Head of JLABS @ Washington, DC, to…
November 3, 2024
Join the Indo US Bridging RARE Summit 2024: Advancing Global Collaborations in Rare Disease Research
The Indo US Bridging RARE Summit 2024 is set to be an unmissable event for those dedicated to advancing rare…
November 3, 2024
BioFactura Receives $7.8 Million in Funding for Contract Options for its Smallpox Biodefense Therapeutic
FREDERICK, MARYLAND, November 4, 2024: BioFactura, Inc. recently announced contract option activations totaling $7.8 million by the Biomedical Advanced Research…